Roadside Drug Testing Market
Number of pages: 100 | Report Format: PDF | Published date: April 14, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 467.28 million |
|
Market Size Value in 2031 |
US$ 802.96 million |
|
CAGR |
6.2% |
|
Base Year For Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Sample Type, Substance, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global roadside drug testing market was valued at US$ 467.28 million in 2022 and is expected to register a revenue CAGR of 6.2% to reach US$ 802.96 million by 2031.
Roadside Drug Testing Market Fundamentals
Roadside drug testing uses devices and technologies law enforcement agencies use to test drivers for drug impairment while on the road. Law enforcement officials can identify and detain drivers impaired by drugs using these tests, which are frequently administered utilizing handheld devices that can quickly detect the presence of drugs in a driver's system (DUID). Due to rising public awareness of the risks associated with drugged driving and the demand for effective strategies to counteract it, the market for roadside drug testing has been gradually expanding in recent years. Depending on the jurisdiction and the substance being tested for, various techniques can be used for roadside drug testing, including saliva, blood, or urine tests. Common drugs like marijuana, cocaine, amphetamines, opioids, and benzodiazepines, among others, may be detected by these tests. Roadside drug testing processes can change based on the region and local regulations. Among others, Alere Inc., Drägerwerk AG & Co. KGaA, Thermo Fisher Scientific Inc., Lifeloc Technologies Inc., and OraSure Technologies Inc. are some of the major participants in the market for roadside drug testing. To fulfill the rising demand for roadside drug testing equipment, these businesses are actively involved in research and development efforts to create novel drug testing technologies and broaden their product lines.
[25]
Roadside Drug Testing Market Dynamics
The global roadside drug testing market revenue is expected to grow significantly during the forecast period due to various driving factors. With the growing awareness about the risks and consequences of drug-impaired driving, governments, and law enforcement agencies in many countries are implementing stricter regulations and policies to combat this issue. According to the National Highway Traffic Safety Administration, drinking and driving results in the deaths of 28 people a day in the United States, or one person every 52 minutes (NHTSA). More than 10,000 lives are lost annually because of drunk driving. Roadside drug testing is being increasingly adopted to deter drug-impaired driving and ensure road safety, which is expected to drive the revenue growth of the global roadside drug testing market. The development of advanced drug testing technologies, such as saliva-based drug tests, breathalyzers, and portable devices that can quickly detect multiple drugs, has improved the accuracy and efficiency of roadside drug testing. These technological advancements have made drug testing more convenient, reliable, and accessible, which is expected to boost the demand for roadside drug testing. Legalizing recreational marijuana in some countries and states has raised concerns about the potential increase in drug-impaired driving incidents. According to a report recently created from information in the Federal Motor Carrier Safety Administration's Drug & Alcohol Clearinghouse, about 41,000 truck drivers tested positive for marijuana in the United States in 2022, a 32% increase over 2021. This has led to a greater emphasis on roadside drug testing to detect marijuana and other drugs in drivers, which is expected to drive market revenue growth. Roadside drug testing is often conducted using point-of-care testing devices, which offer rapid and on-the-spot detection of drugs in drivers. The growing adoption of point-of-care testing in various healthcare settings is expected to drive the revenue growth of the roadside drug testing market. For instance, the DDS2 Mobile Test System is a cutting-edge portable drug testing system created and produced by Alere, Inc. (Abbott). Within five minutes, it can tell if a driver has cocaine, marijuana, opiate, amphetamine, or methamphetamine addiction.
However, the global roadside drug testing market may also face challenges such as legal and ethical concerns, potential false positives or negatives in drug testing results, and concerns related to privacy and consent.
Roadside Drug Testing Market Ecosystem
The global roadside drug testing market is analyzed from four perspectives: sample type, substance, end user, and region.
Roadside Drug Testing Market by Sample Type
[69]
Based on the sample type, the global roadside drug testing market is segmented into saliva, breath, and others.
The breath segment accounts for the largest revenue share in the global roadside drug testing market. Breath is the sample that is most frequently used to detect alcohol. Alcohol is the substance that drivers abuse the most often. Manufacturers concentrate on developing quick tests that are less expensive, easier to use, and offer results faster than lab tests. The saliva segment is projected to record a high revenue CAGR during the forecast period. Drug detection at the roadside using oral fluid or saliva is prevalent in many nations.
Roadside Drug Testing Market by Substance
Based on substance, the global roadside drug testing market is segmented into alcohol and drugs.
The alcohol segment accounts for the largest global roadside drug testing market revenue share. This is because alcohol is the substance that drivers abuse the most frequently. The global roadside drug testing market is growing more quickly than normal due to rising alcohol use and an uptick in occurrences involving drunk driving. The expanding effects of alcohol misuse on public health and the legalization of equipment for roadside drug testing also contribute to the revenue growth of the global market.
Roadside Drug Testing Market by End User
Based on the end user, the global roadside drug testing market is segmented into drug enforcement agencies, highway police, and others.
The highway police segment accounts for the largest revenue share in the global roadside drug testing market. This is due to the rise in people operating motor vehicles while intoxicated or under the influence of drugs, from approximately 66.7 million vehicles sold globally in 2021 to approximately 67.2 million vehicles sold globally in 2022. The highway police discovered that 23% of car buyers were operating their vehicles under the influence of alcohol and/or drugs. Also, in the United States, the highway police collected 63% of the fine from drivers who were intoxicated in 2021.
Roadside Drug Testing Market by Region
Based on region, the global roadside drug testing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounts for the largest global roadside drug testing market revenue share. Increasing concerns about drug-impaired driving, a significant public health and safety issue, have driven the demand for roadside drug testing devices and technologies in North America. Legalizing recreational and medical marijuana in some states and provinces in North America has also raised concerns about the potential increase in drug-impaired driving incidents. As a result, there has been a growing need for effective roadside drug testing solutions to identify and deter drug-impaired driving. The roadside drug testing market in North America is also influenced by regulatory frameworks and policies related to drug-impaired driving. Different states and provinces may have varying laws and regulations regarding using roadside drug testing devices, including the permissible types of tests, the legal limits for drug impairment, and the consequences of a positive drug test. These regulations can impact the region's adoption and usage of roadside drug testing technologies.
The roadside drug testing market in the Asia Pacific is expected to experience significant revenue growth during the forecast period. There is a growing awareness among governments, law enforcement agencies, and the general public about the dangers of impaired driving due to drugs. This leads to stricter regulations and policies mandating roadside drug testing to detect and prevent drug-impaired driving. The Asia Pacific region is witnessing an increase in drug abuse cases, including the abuse of illicit and prescription drugs. This is leading to a greater emphasis on detecting drug-impaired drivers and preventing accidents caused by drug abuse. Governments in the Asia Pacific region are taking initiatives to combat drug-impaired driving by implementing strict regulations, conducting awareness campaigns, and investing in roadside drug testing infrastructure. These efforts are expected to fuel the growth of the roadside drug testing market in the region. The Asia Pacific region is a popular tourist destination with a booming transportation industry, including public transportation and ride-hailing services. The need to ensure road safety and prevent drug-impaired driving incidents among tourists and transportation operators drives the demand for roadside drug testing.
Competitive Landscape of the Roadside Drug Testing Market
The prominent players operating in the global roadside drug testing market are: -
Strategic Developments in Roadside Drug Testing Market
The expected size of the global roadside drug testing market in 2031 is US$ 802.96 million.
The expected revenue CAGR for the roadside drug testing market is 6.2% during the forecast period.
Cannabix Technologies, Inc., UriTox LLC, Thermo Fisher Scientific, Inc., Abbott Laboratories Inc., Countermeasure Systems Corporation, and Agilent Technologies are some of the major players in the roadside drug testing market.
The Asia Pacific region is expected to grow at high revenue CAGR in the global roadside drug testing market.
The global roadside drug testing market faces several challenges related to legal and regulatory complexities, accuracy and reliability of testing devices, detection of new and emerging drugs, privacy and civil liberties concerns, training and expertise of law enforcement personnel, cost-effectiveness and accessibility, and public perception and acceptance.
*Insights on financial performance are subject to the availability of information in the public domain